Company / Operating Margin
ARS Pharmaceuticals, Inc. Operating Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-212.9%
FY2025
5-year range
-225066.7% / -3.5%
FY2022-FY2025
Trend
-6053.8%
vs FY2024
Sector context
#99 of 136
Health Care
What the data says
Operating Margin changed -6054% YoY in FY2025, a notable deviation from the 3-year average annual change of -23185%.
Based on SEC 10-K filings.
-212.9% in FY2025 with a 3-year CAGR of +140.4%.
Improved from -225066.7% to -212.9% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +140.4pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#99 of 136 in Health CareTop 73% of 136This company -212.9% Sector average -778.9%
▼
+72.7% above sector average
Key checks
Key Insights
- In FY2025, operating margin decreased 6053.8% year-over-year.
- Currently 566.0pp above the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -212.9% | -6053.8% |
| FY2024 | -3.5% | +100.0% |
| FY2023 | -225066.7% | -63600.5% |
| FY2022 | -353.3% | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026